BMPR1A (ALK3) Protein
Overview
BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a serine/threonine kinase receptor for Bone Morphogenetic Protein (BMP) ligands. BMPR1A mediates BMP signaling in embryonic development, tissue homeostasis, and adult tissue repair. In the nervous system, BMPR1A regulates neural stem cell proliferation and differentiation, oligodendrocyte development, and neuroprotection. Dysregulation of BMPR1A signaling contributes to neurodevelopmental disorders, neurodegenerative diseases, and failed neural repair. [@liu2009]
BMPR1A represents a critical component of the BMP signaling pathway, one of the most important developmental signaling cascades in vertebrates. Its role in the central nervous system extends from early neural tube patterning to adult neural progenitor regulation and tissue repair.
...
BMPR1A (ALK3) Protein
Overview
BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), also known as ALK3 (Activin receptor-Like Kinase 3), is a serine/threonine kinase receptor for Bone Morphogenetic Protein (BMP) ligands. BMPR1A mediates BMP signaling in embryonic development, tissue homeostasis, and adult tissue repair. In the nervous system, BMPR1A regulates neural stem cell proliferation and differentiation, oligodendrocyte development, and neuroprotection. Dysregulation of BMPR1A signaling contributes to neurodevelopmental disorders, neurodegenerative diseases, and failed neural repair. [@liu2009]
BMPR1A represents a critical component of the BMP signaling pathway, one of the most important developmental signaling cascades in vertebrates. Its role in the central nervous system extends from early neural tube patterning to adult neural progenitor regulation and tissue repair.
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">BMPR1A Receptor</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>BMPR1A</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>ALK3, BRK-1, SKK5</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>10q22.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>652</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P36894</td></tr>
<tr><td><strong>Protein Length</strong></td><td>532 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~60 kDa</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Serine/threonine kinase receptors</td></tr>
<tr><td><strong>Ligands</strong></td><td>BMP2, BMP4, BMP6, BMP7, BMP9, BMP10</td></tr>
<tr><td><strong>Expression</strong></td><td>Neural stem cells, neurons, glia</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">18 edges</a></td>
</tr>
</table>
</div>
Gene and Protein Structure
BMPR1A Gene Organization
The BMPR1A gene spans approximately 44 kb on chromosome 10q22.3 and consists of 13 exons. The gene encodes a transmembrane receptor protein that is essential for BMP signal transduction. Multiple alternatively spliced variants have been identified with tissue-specific expression patterns.
Protein Domain Architecture
BMPR1A contains distinct functional domains:
Extracellular Domain (~160 aa): Contains the ligand-binding region for BMP proteins. This domain includes:
- N-terminal signal peptide (1-20 aa)
- Cysteine-rich domain (CRD) for ligand binding
- Glycosylation sites for proper folding
Transmembrane Domain (~30 aa): Single α-helical transmembrane segment that anchors the receptor in the plasma membrane.
GS Domain (~60 aa): Glycine-serine rich region immediately intracellular to the transmembrane domain. This is the site where type II receptors phosphorylate BMPR1A.
Kinase Domain (~270 aa): Intracellular serine/threonine kinase domain with:
- ATP-binding site
- Substrate-binding region
- Activation loop for kinase activity
BMPR1A functions as a type I receptor in BMP signaling complexes:
- Type II receptors: BMPR2 (BMPR type II), ACVR2A, ACVR2B
- Co-receptors: Endogin (ENG), betaglycan (TGFBR3) can modulate signaling
- Accessory receptors: Various proteins that regulate ligand presentation
Normal Physiological Functions
BMP Signaling Pathway
BMPR1A mediates canonical BMP signaling:
Ligand binding: BMP2, BMP4, BMP6, BMP7 bind to BMPR1A in complex with type II receptors
Complex formation: Type II receptor phosphorylates GS domain of BMPR1A
SMAD activation: Activated BMPR1A phosphorylates SMAD1/5/8 (R-SMADs)
Complex formation: R-SMADs form complexes with SMAD4 (Co-SMAD)
Nuclear translocation: SMAD complex translocates to the nucleus
Gene transcription: Regulates target gene expressionNon-Canonical BMP Signaling
BMPR1A also activates non-SMAD pathways:
- MAPK pathways: ERK, p38, JNK
- PI3K/AKT pathway
- Rho GTPase pathways
Role in Neural Development
Neural Tube Patterning
During early neural development, BMPR1A signaling patterns the neural tube:
- Dorsal-ventral patterning: BMP gradients specify cell fates
- Boundary formation: Establishes regional identities
- Floor plate development: Regulates ventral patterning
Neural Stem Cell Regulation
BMPR1A is critical for neural stem/progenitor cell biology: [@liu2009]
- Proliferation: BMP signaling promotes neural progenitor proliferation
- Self-renewal: Maintains stem cell identity
- Differentiation: Guides fate decisions toward neurons or glia
Neuronal Differentiation
During neuronal development:
- Promotes neurogenesis in specific brain regions
- Regulates neuronal subtype specification
- Controls axon guidance and synapse formation
- Modulates neuronal migration
Gliogenesis
BMPR1A influences glial cell development:
- Astrocyte differentiation: BMP signaling promotes astrogliogenesis
- Oligodendrocyte specification: Initial steps of oligodendrocyte lineage commitment
- Glial homeostasis: Maintains glial cell function
Role in Oligodendrocyte Biology
Oligodendrocyte Differentiation
BMPR1A plays a critical role in oligodendrocyte development: [@xiao2019]
- Specification: BMP signaling specifies oligodendrocyte lineage
- Proliferation: Regulates oligodendrocyte progenitor cell (OPC) expansion
- Differentiation: Promotes progression from progenitors to mature oligodendrocytes
- Myelination: Coordinates myelination programs
Demyelinating Diseases
In multiple sclerosis and related demyelinating conditions:
- Remyelination failure: BMPR1A signaling often dysregulated
- OPC recruitment: Impaired oligodendrocyte progenitor recruitment
- Differentiation block: OPCs fail to mature into oligodendrocytes
Therapeutic Potential
BMPR1A manipulation shows promise for demyelinating diseases:
- BMPR1A agonists enhance remyelination
- BMP antagonists promote oligodendrocyte differentiation
- Gene therapy approaches in development
Role in Neurodegeneration
Alzheimer's Disease
BMPR1A signaling is altered in Alzheimer's disease: [@chen2017]
Neurogenesis and BMPR1A
- BMP signaling in neural progenitor cells of the hippocampus
- Adult neurogenesis impaired in AD
- BMPR1A may influence hippocampal plasticity
Amyloid and Tau Interaction
- BMP signaling modulated by amyloid pathology
- Links to tau pathology and synaptic dysfunction
- May affect neuroinflammation
Therapeutic Implications
- BMPR1A modulators for cognitive enhancement
- BMP signaling enhancement for neuroprotection
- Targeting downstream SMAD pathways
Parkinson's Disease
In Parkinson's disease, BMPR1A signaling has complex roles: [@khalil2019]
Dopaminergic Neurons
- BMP signaling supports dopaminergic neuron survival
- Neuroprotective effects in experimental models
- May promote regeneration of damaged neurons
Glial Interactions
- Modulates microglial activation
- Affects astrocyte function
- Links to neuroinflammation
Therapeutic Potential
- BMP-based neuroprotective strategies
- Combination with other neurotrophic factors
- Gene therapy approaches
Stroke and Brain Injury
BMPR1A is involved in post-injury repair: [@samtani2020]
Neural Repair Mechanisms
- Promotes neurogenesis after stroke
- Enhances angiogenesis
- Modulates inflammation
- Supports functional recovery
Therapeutic Window
- Acute phase: anti-inflammatory effects
- Subacute: promotes neurogenesis
- Chronic: supports remodeling
Amyotrophic Lateral Sclerosis
In ALS:
- Altered BMP signaling in motor neurons
- Affects glial function
- Modulates neuroinflammation
- Potential for neuroprotective strategies
Expression Pattern in the CNS
| Cell Type | Expression | Function |
|-----------|-----------|----------|
| Neural Stem Cells | High | Self-renewal, differentiation |
| Neurons | Moderate | Synaptic plasticity, survival |
| Astrocytes | High | Regulation of signaling |
| Oligodendrocyte Progenitors | High | Proliferation, differentiation |
| Mature Oligodendrocytes | Low | Myelin maintenance |
| Microglia | Moderate | Modulation of signaling |
Signaling Pathways Activated by BMPR1A
Canonical SMAD Pathway
SMAD1/5/8 phosphorylation: R-SMAD activation
SMAD complex formation: With SMAD4
Nuclear translocation: Gene regulation
Target genes: ID proteins, Noggin, Smad6/7Non-Canonical Pathways
MAPK/ERK pathway: Cell proliferation, survival
p38 pathway: Stress responses, differentiation
PI3K/AKT pathway: Cell survival
Rho GTPases: Cytoskeletal dynamicsTherapeutic Targeting
BMPR1A Agonists
Approaches to enhance BMPR1A signaling:
| Agent | Mechanism | Status | Notes |
|-------|-----------|--------|-------|
| BMP4 protein | Direct agonist | Preclinical | Limited BBB penetration |
| BMP7 protein | Direct agonist | Clinical trials | Osteogenic, CNS effects |
| Small molecule agonists | Kinase activation | Discovery | Limited specificity |
| Gene therapy | Increased expression | Preclinical | Viral vector delivery |
BMPR1A Antagonists
For conditions where BMP signaling is excessive:
| Agent | Mechanism | Status | Notes |
|-------|-----------|--------|-------|
| Noggin | BMP ligand sequestration | Preclinical | Protein therapeutic |
| Chordin | BMP ligand sequestration | Research | Limited availability |
| Dorsomorphin | Kinase inhibition | Research | Non-selective |
| LDN-193189 | Kinase inhibition | Preclinical | BMPR1A/ALK2 selective |
Clinical Applications
- Demyelinating diseases: BMPR1A agonists for remyelination
- Stroke recovery: BMP-based therapies
- Neurodegeneration: Neuroprotective strategies
- Spinal cord injury: Combinatorial approaches
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
- [SMAD Proteins](/proteins/smad-protein)
- [BMPR2 Protein](/proteins/bmpr2-protein)
- [Neural Stem Cells](/cell-types/neural-stem-cells)
- [Oligodendrocyte Precursor Cells](/cell-types/oligodendrocyte-precursor-cells)
- [Neural Progenitor Cells](/cell-types/neural-progenitor-cells)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Stroke](/diseases/stroke)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Myelination](/mechanisms/myelination)
Key Publications
[BMP signaling in neural stem and progenitor cells, Cell Stem Cell (2009)](https://pubmed.ncbi.nlm.nih.gov/19633590/)
[BMP type I receptor complexes, J Mol Biol (2021)](https://pubmed.ncbi.nlm.nih.gov/33705733/)
[BMP signaling in neural repair after stroke, Stroke (2020)](https://pubmed.ncbi.nlm.nih.gov/32093457/)
[BMP/SMAD signaling in oligodendrocyte differentiation, J Mol Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/30627745/)
[BMP signaling in neural development and disease, Dev Neurobiol (2020)](https://pubmed.ncbi.nlm.nih.gov/32053782/)
[BMP signaling in Alzheimer's disease, Nat Rev Neurosci (2017)](https://pubmed.ncbi.nlm.nih.gov/28964251/)
[BMP signaling in Parkinson's disease, Cell Death Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/30683852/)
[BMP-SMAD signaling in oligodendrocyte biology, Glia (2020)](https://pubmed.ncbi.nlm.nih.gov/32092154/)
[BMP signaling in demyelination and remyelination, J Neurosci Res (2020)](https://pubmed.ncbi.nlm.nih.gov/31729127/)
[BMP receptor signaling in CNS development, Development (2018)](https://pubmed.ncbi.nlm.nih.gov/29760283/)References
[Liu A, et al, BMP signaling in neural stem and progenitor cells, Cell Stem Cell (2009)](https://pubmed.ncbi.nlm.nih.gov/19633590/)
[Nickel J, et al, BMP type I receptor complexes, J Mol Biol (2021)](https://pubmed.ncbi.nlm.nih.gov/33705733/)
[Samtani R, et al, BMP signaling in neural repair after stroke, Stroke (2020)](https://pubmed.ncbi.nlm.nih.gov/32093457/)
[Xiao L, et al, BMP/SMAD signaling in oligodendrocyte differentiation, J Mol Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/30627745/)
[Abreu JG, et al, BMP signaling in neural development and disease, Dev Neurobiol (2020)](https://pubmed.ncbi.nlm.nih.gov/32053782/)
[Chen HL, et al, BMP signaling in Alzheimer's disease, Nat Rev Neurosci (2017)](https://pubmed.ncbi.nlm.nih.gov/28964251/)
[Khalil H, et al, BMP signaling in Parkinson's disease, Cell Death Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/30683852/)
[Cunningham DL, et al, BMP-SMAD signaling in oligodendrocyte biology, Glia (2020)](https://pubmed.ncbi.nlm.nih.gov/32092154/)
[See J, et al, BMP signaling in demyelination and remyelination, J Neurosci Res (2020)](https://pubmed.ncbi.nlm.nih.gov/31729127/)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Stroke](/diseases/stroke)
- [Neural Stem Cells](/cell-types/neural-stem-cells)
- [Oligodendrocyte Precursor Cells](/cell-types/oligodendrocyte-precursor-cells)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Myelination](/mechanisms/myelination)
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
External Links
- [NCBI Gene: BMPR1A](https://www.ncbi.nlm.nih.gov/gene/652)
- [UniProt: P36894](https://www.uniprot.org/uniprot/P36894)
- [HGNC: BMPR1A](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1267)
- [KEGG Pathway: BMP signaling](https://www.genome.jp/kegg/pathway.html)